Evommune, Inc. (EVMN)
NYSE: EVMN · Real-Time Price · USD
25.60
+0.60 (2.40%)
At close: Apr 28, 2026, 4:00 PM EDT
25.58
-0.02 (-0.08%)
After-hours: Apr 28, 2026, 4:00 PM EDT
Evommune Stock Forecast
Stock Price Forecast
The 8 analysts with 12-month price forecasts for Evommune stock have an average target of 43.88, with a low estimate of 36 and a high estimate of 53. The average target predicts an increase of 71.41% from the current stock price of 25.60.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Evommune stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 2 | 2 | 3 | 3 |
| Buy | 5 | 6 | 6 | 6 | 7 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 8 | 8 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Reiterates $48 | Buy | Reiterates | $48 | +87.50% | Apr 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $65 → $50 | Strong Buy | Maintains | $65 → $50 | +95.31% | Mar 18, 2026 |
| Clear Street | Clear Street | Strong Buy Initiates $53 | Strong Buy | Initiates | $53 | +107.03% | Mar 18, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $35 → $65 | Strong Buy | Maintains | $35 → $65 | +153.91% | Feb 10, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $42 | Buy | Initiates | $42 | +64.06% | Jan 22, 2026 |
Financial Forecast
Revenue This Year
n/a
from 13.00M
Revenue Next Year
n/a
EPS This Year
-2.81
from -11.22
EPS Next Year
-3.28
from -2.81
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | n/a | n/a | ||||||
| Avg | n/a | n/a | ||||||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -2.36 | -2.73 | ||||||
| Avg | -2.81 | -3.28 | ||||||
| Low | -3.02 | -3.41 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.